Eclipsebio is proud to announce the 2025 Data Catalyst Award. The Data Catalyst Award recognizes RNA researchers who are at the forefront of using data to solve the biggest challenges in understanding RNA biology or developing effective therapeutics. Award winners will receive matching funds from Eclipsebio to cover the cost of generating the control datasets for their experiments. In return, participating awardees agree to contribute their control data to Eclipsebio’s growing collection of AI-ready RNA datasets to support our partners’ basic research and drug discovery programs.
This initiative is part of Eclipsebio’s commitment to enabling high-impact science and building a robust foundation for training accurate, reliable AI models in RNA medicine.
For more information and to apply for the award visit https://eclipsebio.co/data-catalyst-award-2025. All applications must be received by June 16th, 2025.
Latest news
RNA Delivery Prato 2026
Eclipsebio is proud to sponsor the 2026 RNA Delivery Prato meeting to discuss recent discoveries and challenges in RNA delivery.
Eclipsebio Expands eCOMPASS™ Platform with eSENSE Break™ to Map RNA Fragmentation at Nucleotide Resolution
Eclipsebio's eSENSE Break uses sequencing-based analytics to map RNA fragmentation and circular RNA nicking sites at single-nucleotide resolution.
2026 Data Catalyst Award Call for Applications
The Data Catalyst Award helps offset the cost of RNA profiling experiments using Eclipsebio's assays from our RNA profiling portfolio and contributes to the eVERSE database.
Eclipsebio Launches eCOMPASS™, an AI-Enabled Lab-in-the-Loop Platform for RNA Therapeutic Development
Eclipsebio's eCOMPASS platform combines AI-optimized design and sequencing-based analytics to produce successful RNA therapeutics efficiently.